Investors / filer profile

McCulloch Kevin

See Remarks

active in 1 company · 1 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 11
Filings: 1
Companies: 2026-09-01
Last filed

EDGAR · CIK 0002031695 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+54.5%

median move per position

+14.6%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$109.5K bought · −$247.3K sold

All filings on record

Every Form 4 transaction we track for this filer


XERSXeris Biopharma Holdings, Inc.	Sell $127.3K · 15,000 sh	2026-09-01	—
XERSXeris Biopharma Holdings, Inc.	Tax $177.1K · 21,918 sh	2026-08-01	—
XERSXeris Biopharma Holdings, Inc.	Tax $201.1K · 27,319 sh	2026-01-31	—
XERSXeris Biopharma Holdings, Inc.	Tax $222.9K · 30,289 sh	2026-01-31	—
XERSXeris Biopharma Holdings, Inc.	Tax $503.8K · 68,454 sh	2026-01-31	—
XERSXeris Biopharma Holdings, Inc.	Grant — · 168,463 sh	2026-01-30	—
XERSXeris Biopharma Holdings, Inc.	Sell $120.0K · 15,000 sh	2026-01-08	—
XERSXeris Biopharma Holdings, Inc.	Tax $6.1K · 733 sh	2025-10-02	—
XERSXeris Biopharma Holdings, Inc.	Other — · 2,000 sh	2025-09-11	—
XERSXeris Biopharma Holdings, Inc.	Tax $78.8K · 14,651 sh	2025-08-01	—

XERSSell

2026-09-01 · Xeris Biopharma Holdings, Inc.

$127.3K

—

XERSTax

2026-08-01 · Xeris Biopharma Holdings, Inc.

$177.1K

—

XERSTax

2026-01-31 · Xeris Biopharma Holdings, Inc.

$201.1K

—

XERSTax

2026-01-31 · Xeris Biopharma Holdings, Inc.

$222.9K

—

XERSTax

2026-01-31 · Xeris Biopharma Holdings, Inc.

$503.8K

—

XERSGrant

2026-01-30 · Xeris Biopharma Holdings, Inc.

168,463

—

XERSSell

2026-01-08 · Xeris Biopharma Holdings, Inc.

$120.0K

—

XERSTax

2025-10-02 · Xeris Biopharma Holdings, Inc.

$6.1K

—

XERSOther

2025-09-11 · Xeris Biopharma Holdings, Inc.

2,000

—

XERSTax

2025-08-01 · Xeris Biopharma Holdings, Inc.

$78.8K

—

Newest 10 of 11 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.